Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients

scientific article

Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.YGYNO.2012.07.001
P698PubMed publication ID22800653

P50authorJesper HallasQ43490380
P2093author name stringJørn Herrstedt
Merete Paludan
Laurids Østergaard Poulsen
Anni Young Stensgård Jørgensen
Karin Herskind Bruun
Sandra Teiblum
Trine Lembrecht Jørgensen
P2860cites workGlobal cancer statisticsQ22241238
ASA physical status classifications: a study of consistency of ratingsQ28276157
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' GroupQ31962966
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year resultsQ33332312
Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.Q33333839
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group studyQ33348987
Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database.Q33420943
Single agents should be administered in preference to combination chemotherapy for the treatment of patients over 70 years of age with advanced ovarian carcinoma.Q33900899
Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderlyQ35214119
Ovarian cancer in younger vs older women: a population-based analysisQ36611969
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter studyQ36760924
Comprehensive geriatric assessment for older patients with cancerQ36815525
Older female cancer patients: importance, causes, and consequences of undertreatmentQ36815538
Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group StudyQ36912591
Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?Q37169893
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus ConferenceQ37872164
Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) scoreQ39688507
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancerQ40673230
The Danish Cancer RegistryQ45848855
The Danish Register of Causes of Death.Q50554191
Survival and prognostic factors in patients with ovarian cancerQ53301800
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancerQ57903823
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experienceQ57904796
GRADING OF PATIENTS FOR SURGICAL PROCEDURESQ62567994
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR GermanyQ79326663
Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patientsQ79797677
Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patientsQ80665192
The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based studyQ81574365
Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualizationQ84602056
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectovarian cancerQ172341
comorbidityQ1414874
adherence (medicine)Q67004728
P304page(s)367-374
P577publication date2012-07-16
P1433published inGynecologic OncologyQ5625182
P1476titleSignificance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients
P478volume127